The results of this study demonstrate that SPS can be an appropriate model for studying at least some of the features of PTSD in females and that intranasal NPY at a high dose can provide early therapeutic intervention, likely as a Y1R agonist. The gene discussed is NPY; the disease is post-traumatic stress disorder.